Aucuba Sciences Ltd specializes in Drug Metabolism and Pharmacokinetics (DMPK) and Clinical Pharmacology consultancy, providing expert guidance to pharmaceutical, biotechnology, academic, and charitable organizations. Their services encompass a comprehensive review of ongoing drug discovery and development programs, focusing on the interpretation and integration of DMPK data. They offer specialized expertise in inhaled drug projects and assist in designing and conducting studies related to Absorption, Distribution, Metabolism, and Excretion (ADME), pharmacokinetics (PK), toxicokinetics (TK), and pharmacokinetic/pharmacodynamic (PK/PD) modeling. Aucuba Sciences also supports regulatory submissions by drafting DMPK sections of key documents and managing interactions with global regulatory agencies.

In the realm of Clinical Pharmacology, Aucuba Sciences formulates program-specific development plans and provides guidance for various clinical study designs, including First-in-Human (FIH) studies, drug-drug interaction assessments, and studies involving special populations such as pediatrics. Their expertise extends to the interpretation of industry guidance documents and the application of pharmacokinetic modeling to optimize clinical study designs and inform dosing strategies. Additionally, they assist in drafting clinical pharmacology sections for regulatory submissions and engage in due diligence activities related to in-licensing and outsourcing.

United Kingdom

PROVIDING DMPK & CLINICAL PHARMACOLOGY EXPERTISE TO PHARMA, BIOTECH, ACADEMIC & CHARITABLE ORGANISATIONS.
Aucuba Sciences Ltd was established in 2016. Specialising in DMPK and Clinical Pharmacology knowledge for drug discovery and development programmes, the company provides advice and expertise to assist in the resolution of drug discovery and development challenges.

Aucuba Sciences

Company Details